Poziotinib hydrochloride irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. It is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 88 | |
10 mg | In stock | $ 167 | |
20 mg | In stock | $ 223 | |
50 mg | In stock | $ 525 | |
100 mg | In stock | $ 787 |
Description | Poziotinib hydrochloride irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. It is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. |
Synonyms | HM 781-36B hydrochloride, NOV120101 hydrochloride |
CAS No. | 1429757-68-5 |
Chemical Formula | C23H22Cl3FN4O3 |
Molecular Weight | 527.8 |
Solubility | DMSO: 10 mM |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom